Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
Authors
Keywords
-
Journal
Viruses-Basel
Volume 6, Issue 2, Pages 391-403
Publisher
MDPI AG
Online
2014-01-28
DOI
10.3390/v6020391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus
- (2014) Norbert Varga et al. BIOMATERIALS
- Selective Targeting of Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin (DC-SIGN) with Mannose-Based Glycomimetics: Synthesis and Interaction Studies of Bis(benzylamide) Derivatives of a Pseudomannobioside
- (2013) Norbert Varga et al. CHEMISTRY-A EUROPEAN JOURNAL
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Adjuvants: Mode of Action
- (2013) Ennio De Gregorio et al. Frontiers in Immunology
- Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation
- (2012) Yvette van Kooyk et al. MOLECULAR IMMUNOLOGY
- A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models
- (2011) Angela Berzi et al. AIDS
- Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: Findings, implications and open questions
- (2011) Roland Lang et al. IMMUNOBIOLOGY
- Codelivery of the Chemokine CCL3 by an Adenovirus-Based Vaccine Improves Protection from Retrovirus Infection
- (2011) R. Lietz et al. JOURNAL OF VIROLOGY
- Innate immunity and adjuvants
- (2011) S. Akira PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
- (2011) M. K. L. MacLeod et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
- (2011) Marc P. Girard et al. VACCINE
- Inhibition of DC-SIGN-Mediated HIV Infection by a Linear Trimannoside Mimic in a Tetravalent Presentation
- (2010) Sara Sattin et al. ACS Chemical Biology
- C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity
- (2010) Urban Švajger et al. CELLULAR SIGNALLING
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Proinflammatory Adjuvants Enhance the Cognate Helper Activity of Aged CD4 T Cells
- (2009) Alexander C. Maue et al. JOURNAL OF IMMUNOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ‘immunologic advantage’ of HIV-exposed seronegative individuals
- (2008) Masaaki Miyazawa et al. AIDS
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
- (2008) David G. Brooks et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The hunt for an HIV vaccine: time to rethink recent failures
- (2008) Adriano Boasso et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now